Bloomage BioTechnology Corporation Limited (688363.SS)
CNY 46.08
(5.18%)
CNY 46.08
(5.18%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 4.28 Billion CNY | -12.5% |
| 2022 | 4.89 Billion CNY | 26.76% |
| 2021 | 3.86 Billion CNY | 80.22% |
| 2020 | 2.14 Billion CNY | 42.69% |
| 2019 | 1.5 Billion CNY | 48.78% |
| 2018 | 1 Billion CNY | 63.5% |
| 2017 | 617.45 Million CNY | 8.87% |
| 2016 | 567.14 Million CNY | 18.73% |
| 2015 | 477.68 Million CNY | 27.25% |
| 2014 | 375.39 Million CNY | 25.19% |
| 2013 | 299.85 Million CNY | 57.28% |
| 2012 | 190.64 Million CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| 2007 | - CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| 2005 | - CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 770.09 Million CNY | -23.88% |
| 2024 Q2 | 1.01 Billion CNY | -0.36% |
| 2024 Q1 | 1.01 Billion CNY | -22.95% |
| 2023 FY | 4.28 Billion CNY | -12.5% |
| 2023 Q2 | 1.3 Billion CNY | 35.7% |
| 2023 Q1 | 962.96 Million CNY | -38.25% |
| 2023 Q3 | 815.02 Million CNY | -37.63% |
| 2023 Q4 | 1.31 Billion CNY | 61.67% |
| 2022 Q2 | 1.3 Billion CNY | 34.84% |
| 2022 Q4 | 1.55 Billion CNY | 46.62% |
| 2022 FY | 4.89 Billion CNY | 26.76% |
| 2022 Q3 | 1.06 Billion CNY | -18.5% |
| 2022 Q1 | 967.89 Million CNY | -36.29% |
| 2021 Q3 | 834.46 Million CNY | -7.04% |
| 2021 FY | 3.86 Billion CNY | 80.22% |
| 2021 Q1 | 611.21 Million CNY | -28.27% |
| 2021 Q2 | 897.61 Million CNY | 46.86% |
| 2021 Q4 | 1.51 Billion CNY | 82.06% |
| 2020 Q3 | 535.82 Million CNY | 13.58% |
| 2020 Q1 | 283.62 Million CNY | -41.5% |
| 2020 Q2 | 471.74 Million CNY | 66.32% |
| 2020 FY | 2.14 Billion CNY | 42.69% |
| 2020 Q4 | 852.07 Million CNY | 59.02% |
| 2019 Q1 | 275.54 Million CNY | -18.7% |
| 2019 Q3 | 373.14 Million CNY | 1.26% |
| 2019 FY | 1.5 Billion CNY | 48.78% |
| 2019 Q4 | 484.8 Million CNY | 29.92% |
| 2019 Q2 | 368.51 Million CNY | 33.74% |
| 2018 FY | 1 Billion CNY | 63.5% |
| 2018 Q4 | 338.92 Million CNY | 40.02% |
| 2018 Q3 | 242.05 Million CNY | -4.5% |
| 2018 Q2 | 253.47 Million CNY | 18.83% |
| 2018 Q1 | 213.3 Million CNY | 0.0% |
| 2017 Q2 | 133.01 Million CNY | 0.0% |
| 2017 Q1 | 133.01 Million CNY | -14.21% |
| 2017 FY | 617.45 Million CNY | 8.87% |
| 2016 Q4 | 155.04 Million CNY | 0.0% |
| 2016 Q2 | 141.16 Million CNY | 0.0% |
| 2016 FY | 567.14 Million CNY | 18.73% |
| 2016 Q3 | 155.04 Million CNY | 9.83% |
| 2016 Q1 | 141.16 Million CNY | 9.01% |
| 2015 Q4 | 129.5 Million CNY | 0.0% |
| 2015 FY | 477.68 Million CNY | 27.25% |
| 2015 Q3 | 129.5 Million CNY | 13.48% |
| 2015 Q2 | 114.11 Million CNY | 0.0% |
| 2015 Q1 | 114.11 Million CNY | 20.86% |
| 2014 Q1 | 93.27 Million CNY | 21.21% |
| 2014 Q3 | 94.42 Million CNY | 1.23% |
| 2014 FY | 375.39 Million CNY | 25.19% |
| 2014 Q4 | 94.42 Million CNY | 0.0% |
| 2014 Q2 | 93.27 Million CNY | 0.0% |
| 2013 Q2 | 72.97 Million CNY | 0.0% |
| 2013 Q3 | 76.95 Million CNY | 5.45% |
| 2013 Q4 | 76.95 Million CNY | 0.0% |
| 2013 FY | 299.85 Million CNY | 57.28% |
| 2013 Q1 | 72.97 Million CNY | 59.12% |
| 2012 FY | 190.64 Million CNY | 0.0% |
| 2012 Q4 | 45.86 Million CNY | 0.0% |
| 2012 Q3 | 45.86 Million CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2010 FY | - CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |
| 2007 FY | - CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |
| 2005 FY | - CNY | 0.0% |